leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 00:25:51 - browse：864

Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

“You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Scientists boost immune system in aging mice by making it youthful

focus

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Merck drug for rare lung condition set for approval in U.S.

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: Merck, Vertex, and Viking updates

ARCH Venture Partners is raising $3 billion for a life sciences fund

leisure time

leisure time

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

SAMSHA loosens regulations on methadone treatment centers

Novavax promises a turnaround & Lilly roils the obesity market

Primary care physicians play key roles in Alzheimer's management

Tori Bowie and the unacceptable rates of Black maternal death

FDA drug safety: Singulair case shows systemic surveillance flaws

What does generative AI mean for health care? We asked experts

Decaf coffee targeted by food safety group under obscure FDA rule

In Memoriam: Notable people who died in 2023

Readout Newsletter: Merck, Vertex, and Viking updates

Wikipedia

Quicker fix for pulse oximeters urged during FDA public meeting

Readout LOUD podcast: mifepristone case, GLP

Time to name cancers by genetics, not organ of origin, expert says

Medicare drug price negotiation’s day in court

Merck drug for rare lung condition set for approval in U.S.

Vertex non

entertainment

focus

hotspot

entertainment